Montedison SpA &lt;MONI.MI> has acquired a 70pct stake in &lt;Plant Cell Research Institute - PCRI> ofCalifornia from Atlantic Richfield Co &lt;ARC.N> for "several tensof millions of dollars," a senior Montedison executive said.    Renato Ugo, a member of Montedison's management committee,told reporters that &lt;Stanford Research Institute International>of Menlo Park, California, had acted as a partner in thepurchase, itself acquiring a stake in PCRI of under 10 pct.    PCRI, based in Dublin, California has a biotechnologyresearch laboratory.    Ugo said the price paid included outlays for the laboratorytechnology and staff.    He said other negotiations were under way withbiotechnology companies in the health care and diagnosticssectors through Montedison's health care subsidiary &lt;ErbamontNV>, but gave no details.    "We hope they will be concluded by the year end," he said.    Montedison currently invests around 30 billion lire a yearin biotechnology research and expects to increase this figureto around 50 billion lire in the next few years. Reuter&#3;